(Q34290400)

1 August 2017

title

Efficacy and safety of 15(R/S)-methyl-lipoxin A(4) in topical treatment of infantile eczema (English)

1 reference

1 August 2017

S-H Wu

1

1 reference

1 August 2017

X-Q Chen

2

1 reference

1 August 2017

B Liu

3

1 reference

1 August 2017

H-J Wu

4

1 reference

1 August 2017

L Dong

5

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 January 2013

1 reference

British Journal of Dermatology

1 August 2017

published in

1 reference

1 August 2017

volume

168

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

172-178

1 reference

An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11177.X

Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11177.X

Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11177.X

Molecular mechanisms of topical anti-inflammatory effects of lipoxin A(4) in endotoxin-induced uveitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11177.X

NF-kappaB is involved in inhibition of lipoxin A4 on dermal inflammation and hyperplasia induced by mezerein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11177.X

Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11177.X

Lipoxin A4 inhibits proliferation of human lung fibroblasts induced by connective tissue growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11177.X

Randomized, parallel-group, double-blind, controlled study to evaluate the efficacy and safety of carbohydrate-derived fulvic acid in topical treatment of eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11177.X

Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11177.X

The Infants' Dermatitis Quality of Life Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11177.X

Guidelines for the diagnosis and management of cow's milk protein allergy in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11177.X

Second-generation beta-oxidation resistant 3-oxa-lipoxin A4 analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11177.X

Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11177.X

Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11177.X

Lipoxin A4 inhibits connective tissue growth factor-induced production of chemokines in rat mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11177.X

Signal pathway involved in inhibition by lipoxin A(4) of production of interleukins induced in endothelial cells by lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11177.X

Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11177.X

Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11177.X

Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11177.X

Interdependence of lipoxin A4 and heme-oxygenase in counter-regulating inflammation during corneal wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.11177.X

10.1111/J.1365-2133.2012.11177.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference